Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD). - Ng RA; Barratt S; Parisian A; Palanisamy GS; Phukan S; Sun R; Robello B; Peña G; Sapugay J; Yeghikyan D; Wang C; Satish Kher S; et al. (ACS omega, 2025)